Form D · Other Health Care
Plato BioPharma, Inc.
West Lafayette, IN · CIK 0001494188
Offering snapshot reported Oct 20, 2021 · SEC filing
- Reported sold
- $3M Offering amount: $3M
- Investors reported
- 39 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 4, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 20, 2021 | Initial | $3,000,000 | No comparison | 39 | SEC filing |
| Jun 14, 2010 | Initial | $600,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-417748
Source: Form D, filed Oct 20, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Leasure, Jr. | Director, Executive |
| Craig F. Plato | Director, Executive |
| Beth A. Taylor | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2701 Kent Ave
West Lafayette, IN, 47906-1382
West Lafayette, IN, 47906-1382